Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00434213 · ClinicalTrials.gov registry record · Phase 4
Characterization of Dermal Reactions in Pediatric Patients With ADHD Using DAYTRANA
A Phase 4 study, sponsored by Noven Therapeutics.
- Completed
- Registry status
- Phase 4
- Development phase
- 309
- Enrollment target
NCT00434213: Completed Phase 4 study, sponsored by Noven Therapeutics.
NCT00434213 is a Phase 4 study that has completed, run by Noven Therapeutics. The registered enrollment target is 309 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (40% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00434213, a Phase 4 study, has completed, sponsored by Noven Therapeutics.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 309 participants
- Enrollment target
Study Summary
This is a study designed to characterize the dermal response of DAYTRANA. Subjects will visit the study site over a period of approximately 14 weeks.
Primary Outcome
Dermal reactions were graded on a scale ranging from 0 (no irritation) to 7 (strong reaction) for observed findings of erythema, edema, papules, and vesicles.
Interventions
- DRUG Daytrana
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 309 participants |
| Start Date | 2007-01 |
| Est. Completion | 2008-07 |
| Phase | Phase 4 |
What the finished NCT00434213 record still lists
NCT00434213 is an interventional study that assigns participants to a tested intervention. The registered 309 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (40% lower).
The record links to 0 conditions, and to 1 intervention - of which Daytrana is the first listed.
NCT00434213 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00434213 about?
NCT00434213 is a clinical study titled "Characterization of Dermal Reactions in Pediatric Patients With ADHD Using DAYTRANA". This is a study designed to characterize the dermal response of DAYTRANA. Subjects will visit the study site over a period of approximately 14 weeks.
What is the current status of trial NCT00434213?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 309 participants. The study started on 2007-01. Estimated completion is 2008-07.
What interventions are being tested in trial NCT00434213?
The interventions under investigation include: Daytrana (DRUG).
Who is sponsoring clinical trial NCT00434213?
This trial is sponsored by Noven Therapeutics, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00434213's enrollment target sits among peer trials
309 263rd of 2000 higher than 1,738 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03011684 · 309 participants · Phase 3
Fertility Preservation Using Tamoxifen and Letrozole in Estrogen Sensitive Tumors Trial
- NCT06915233 · 309 participants · Phase 3
A Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the Ankle
- NCT03039439 · 310 participants
Molecular and Immunohistochemical Profiling of Tumors in Patients With Parathyroid Tumors
- NCT04178018 · 310 participants · NA
Transvaginal Ultrasound and Photoacoustic Imaging of Ovary
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia